Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis

Published:2013-12 Issue:12 Volume:35 Page:1997-2006
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Huang Ze-Bing,Zhao Shu-Shan,Huang Yan,Dai Xia-Hong,Zhou Rong-Rong,Yi Pan-Pan,Chen Ruo-Chan,Li Wen-Ting,Zhang Bao-Xin,Li Ning,Fan Xue-Gong

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference55 articles.

1. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach;Pawlotsky;Gastroenterology,2008

2. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection;Liu;J Viral Hepat,2011

3. Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy;Kim;J Gastroenterol Hepatol,2010

4. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

5. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update;Keeffe;Clin Gastroenterol Hepatol,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suboptimal Response to Tenofovir Alafenamide in Two Patients With HBeAg-Positive Hepatitis B: A Case Report;Frontiers in Medicine;2021-07-08

2. Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B;The Korean Journal of Gastroenterology;2021-01-25

3. Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B;KOR J GASTROENTEROL;2021

4. The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis;BMC Gastroenterology;2020-10-19

5. Compare with safety and efficacy of entecavir and adefovir dipivoxil combination therapy and tenofovir disoproxil fumarate monotherapy for chronic hepatitis B patient with adefovir-resistant;Mathematical Biosciences and Engineering;2020